| # | Title | Journal | Year | Citations |
|---|
| 1 | The size and burden of mental disorders and other disorders of the brain in Europe 2010 | European Neuropsychopharmacology | 2011 | 2,930 |
| 2 | Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017 | Pharmacopsychiatry | 2018 | 787 |
| 3 | AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011 | Pharmacopsychiatry | 2011 | 774 |
| 4 | Vasopressin and Oxytocin Excite Distinct Neuronal Populations in the Central Amygdala | Science | 2005 | 724 |
| 5 | The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in Psychiatry | Pharmacopsychiatry | 2004 | 453 |
| 6 | The effect of cognitive behavioral treatment on the positive symptoms of schizophrenia spectrum disorders: A meta-analysis | Schizophrenia Research | 2005 | 327 |
| 7 | Oxytocin Selectively Gates Fear Responses Through Distinct Outputs from the Central Amygdala | Science | 2011 | 324 |
| 8 | Impaired glutathione synthesis in schizophrenia: Convergent genetic and functional evidence | Proceedings of the National Academy of Sciences of the United States of America | 2007 | 275 |
| 9 | Genome-wide association study of recurrent major depressive disorder in two European case–control cohorts | Molecular Psychiatry | 2010 | 215 |
| 10 | Early-Life Insults Impair Parvalbumin Interneurons via Oxidative Stress: Reversal by N-Acetylcysteine | Biological Psychiatry | 2013 | 201 |
| 11 | Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A “central hub” in schizophrenia pathophysiology? | Schizophrenia Research | 2016 | 194 |
| 12 | Combined Efficacy of Acamprosate and Disulfiram in the Treatment of Alcoholism: A Controlled Study | Alcoholism: Clinical and Experimental Research | 1998 | 193 |
| 13 | Antidepressants for the Treatment of Chronic Pain | Drugs | 2008 | 173 |
| 14 | TORC1 is a calcium- and cAMP-sensitive coincidence detector involved in hippocampal long-term synaptic plasticity | Proceedings of the National Academy of Sciences of the United States of America | 2007 | 168 |
| 15 | Pharmacodynamic, Pharmacokinetic and Pharmacogenetic Aspects of Drugs Used in the Treatment of Alzheimer’s Disease | Clinical Pharmacokinetics | 2013 | 156 |
| 16 | CRF1 receptor antagonists attenuate escalated cocaine self-administration in rats | Psychopharmacology | 2008 | 120 |
| 17 | Therapeutic drug monitoring of seven psychotropic drugs and four metabolites in human plasma by HPLC–MS | Journal of Pharmaceutical and Biomedical Analysis | 2009 | 104 |
| 18 | Resistance to cerebral ischemic injury in UCP2 knockout mice: evidence for a role of UCP2 as a regulator of mitochondrial glutathione levels | Journal of Neurochemistry | 2004 | 103 |
| 19 | TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians | World Journal of Biological Psychiatry | 2018 | 103 |
| 20 | Curcumin, quercetin, and tBHQ modulate glutathione levels in astrocytes and neurons: importance of the glutamate cysteine ligase modifier subunit | Journal of Neurochemistry | 2009 | 95 |
| 21 | Treatment and Early Intervention in Psychosis Program (TIPP‐Lausanne): implementation of an early intervention programme for psychosis in Switzerland | Microbial Biotechnology | 2013 | 92 |
| 22 | Impact of Smoking, Smoking Cessation, and Genetic Polymorphisms on CYP1A2 Activity and Inducibility | Clinical Pharmacology and Therapeutics | 2011 | 90 |
| 23 | CCAAT/Enhancer-binding Protein (C/EBP) β Is Acetylated at Multiple Lysines | Journal of Biological Chemistry | 2007 | 89 |
| 24 | Neuron-glia metabolic coupling and plasticity | Experimental Physiology | 2011 | 88 |
| 25 | Evolution of white matter tract microstructure across the life span | Human Brain Mapping | 2019 | 88 |
| 26 | Blood Levels to Optimize Antipsychotic Treatment in Clinical Practice | Journal of Clinical Psychiatry | 2020 | 86 |
| 27 | Influence of ABCB1 genetic polymorphisms on cyclosporine intracellular concentration in transplant recipients | Pharmacogenetics and Genomics | 2008 | 82 |
| 28 | Emerging Roles of CREB-Regulated Transcription Coactivators in Brain Physiology and Pathology | Trends in Neurosciences | 2017 | 82 |
| 29 | Alexithymia Assessment and Relations with Dimensions of Personality | European Journal of Psychological Assessment | 2005 | 79 |
| 30 | Addiction and arousal: The hypocretin connection | Physiology and Behavior | 2008 | 78 |
| 31 | The Number of Genomic Copies at the 16p11.2 Locus Modulates Language, Verbal Memory, and Inhibition | Biological Psychiatry | 2016 | 78 |
| 32 | Parent–child agreement and prevalence estimates of diagnoses in childhood: Direct interview versus family history method | International Journal of Methods in Psychiatric Research | 2009 | 77 |
| 33 | A Genome-Wide Association Study of Neuroticism in a Population-Based Sample | PLoS ONE | 2010 | 71 |
| 34 | Dysfunction of homeostatic control of dopamine by astrocytes in the developing prefrontal cortex leads to cognitive impairments | Molecular Psychiatry | 2020 | 71 |
| 35 | Meta-analysis of the effects of MI training on clinicians' behavior | Journal of Substance Abuse Treatment | 2013 | 66 |
| 36 | The HDAC inhibitor SAHA improves depressive-like behavior of CRTC1-deficient mice: Possible relevance for treatment-resistant depression | Neuropharmacology | 2016 | 66 |
| 37 | European clinical guidelines for Tourette syndrome and other tic disorders—version 2.0. Part III: pharmacological treatment | European Child and Adolescent Psychiatry | 2022 | 64 |
| 38 | Glutathione Precursor N-Acetyl-Cysteine Modulates EEG Synchronization in Schizophrenia Patients: A Double-Blind, Randomized, Placebo-Controlled Trial | PLoS ONE | 2012 | 63 |
| 39 | Anticipatory Pleasure Skills Training: A New Intervention to Reduce Anhedonia in Schizophrenia | Perspectives in Psychiatric Care | 2010 | 62 |
| 40 | Glutamate-induced homocysteic acid release from astrocytes: possible implication in glia-neuron signaling | Neuroscience | 2004 | 59 |
| 41 | Assertive Anger Mediates Effects of Dialectical Behaviour‐informed Skills Training for Borderline Personality Disorder: A Randomized Controlled Trial | Clinical Psychology and Psychotherapy | 2016 | 56 |
| 42 | Caffeine intake and CYP1A2 variants associated with high caffeine intake protect non-smokers from hypertension | Human Molecular Genetics | 2012 | 55 |
| 43 | Blood Pressure in Relation to Coffee and Caffeine Consumption | Current Hypertension Reports | 2014 | 51 |
| 44 | Can Valproic Acid be an Inducer of Clozapine Metabolism? | Pharmacopsychiatry | 2014 | 50 |
| 45 | The AGNP-TDM Expert Group Consensus Guidelines: focus on therapeutic monitoring of antidepressants | Dialogues in Clinical Neuroscience | 2005 | 50 |
| 46 | Improving insight into delusions: a pilot study of metacognitive training for patients with schizophrenia | Journal of Advanced Nursing | 2011 | 48 |
| 47 | Involvement of the agmatinergic system in the depressive-like phenotype of the Crtc1 knockout mouse model of depression | Translational Psychiatry | 2016 | 48 |
| 48 | Neuronal metabolic rewiring promotes resilience to neurodegeneration caused by mitochondrial dysfunction | Science Advances | 2020 | 47 |
| 49 | Social phobia is associated with suicide attempt history in bipolar inpatients | Bipolar Disorders | 2007 | 46 |
| 50 | Personality Changes in Patients with Beginning Alzheimer Disease | Canadian Journal of Psychiatry | 2011 | 46 |
